Skip to main content

Table 4 Best multivariate model of independent predictive biochemical and clinical markers for poor efficacy of TACE therapy

From: Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients

Parameter

Coefficient

Odds-Ratio

95%-Conf. Interval

Chi-Square

P-value

Nucleosomes

(24 h, log2)

0.581

1.79

1.20 - 2.66

8.25

0.0041

Alkaline

Phosphatase

(24 h, log2)

1.561

4.76

1.45 - 15.64

6.62

0.0101

Number of

TACE cycle

0.636

1.89

1.18 - 3.02

7.08

0.0078